Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (491-500 of 941) with videos related to

Pageof 95
Sort By:
Plos One|February 15, 2013
BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cellsChristopher G Low, Iris S U Luk, Dong Lin, et al.
Molecular Cancer Therapeutics|August 23, 2013
Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivoChristian Thomas, Francois Lamoureux, Claire Crafter, et al.
Cancers|September 23, 2018
Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer ModelsSubrata Deb, Steven Pham, Dong-Sheng Ming, et al.
Journal of Cellular Physiology|May 8, 2016
Transcriptome-Based Analysis of Molecular Pathways for Clusterin Functions in Kidney CellsGhida Dairi, Qiunong Guan, Mani Roshan-Moniri, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 18, 2023
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapySara Harsini, Don Wilson, Heather Saprunoff, et al.
Molecular Urology|November 4, 2000
Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observationsN Bruchovsky, L H Klotz, M Sadar, et al.
The Prostate|October 1, 2009
Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancerJunya Furukawa, Christopher J Wraight, Susan M Freier, et al.
The Journal of Urology|June 18, 2004
Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomyAndrew J Stephenson, Michael P Chetner, Keith Rourke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2005
Clusterin as a therapeutic target for radiation sensitization in a lung cancer modelCarolyn Cao, Eric T Shinohara, Hecheng Li, et al.
Journal of Clinical Microbiology|December 14, 2011
Next-generation sequencing of prostate tumors provides independent evidence of xenotropic murine leukemia virus-related gammaretrovirus contaminationFan Mo, Alexander W Wyatt, Chunxiao Wu, et al.
Pageof 95

Showing results (491-500 of 941) with videos related to

Sort By:
Pageof 95
Plos One|February 15, 2013
BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cellsChristopher G Low, Iris S U Luk, Dong Lin, et al.
Molecular Cancer Therapeutics|August 23, 2013
Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivoChristian Thomas, Francois Lamoureux, Claire Crafter, et al.
Cancers|September 23, 2018
Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer ModelsSubrata Deb, Steven Pham, Dong-Sheng Ming, et al.
Journal of Cellular Physiology|May 8, 2016
Transcriptome-Based Analysis of Molecular Pathways for Clusterin Functions in Kidney CellsGhida Dairi, Qiunong Guan, Mani Roshan-Moniri, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 18, 2023
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapySara Harsini, Don Wilson, Heather Saprunoff, et al.
Molecular Urology|November 4, 2000
Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observationsN Bruchovsky, L H Klotz, M Sadar, et al.
The Prostate|October 1, 2009
Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancerJunya Furukawa, Christopher J Wraight, Susan M Freier, et al.
The Journal of Urology|June 18, 2004
Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomyAndrew J Stephenson, Michael P Chetner, Keith Rourke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2005
Clusterin as a therapeutic target for radiation sensitization in a lung cancer modelCarolyn Cao, Eric T Shinohara, Hecheng Li, et al.
Journal of Clinical Microbiology|December 14, 2011
Next-generation sequencing of prostate tumors provides independent evidence of xenotropic murine leukemia virus-related gammaretrovirus contaminationFan Mo, Alexander W Wyatt, Chunxiao Wu, et al.
Pageof 95